This episode covers pivotal regulatory developments spanning the Committee for Medicinal Products for Human Use (CHMP), supply tension management, shortage prevention, environmental carbon reduction initiatives, and sewage discharge legal actions.

Key topics include France’s strict contingentment protocol on Etopophos 100 mg, requiring mandatory prescription validation to prioritize critical patient use. The European Commission’s Executive Steering Group meeting highlights enhanced legislative frameworks mandating shortage prevention plans and supply interruption notifications for marketing authorisation holders.

Additionally, the podcast reviews China’s comprehensive carbon peak and energy-saving policy focusing on industrial efficiency improvements and legal support frameworks. It also outlines a federal complaint against DC Water over sewage discharge violations connected to infrastructure failure.

For more information, visit the Carver Agents website.

Articles mentioned:

1. Tensions d’approvisionnement en Etopophos 100 mg (phosphate d’étoposide) : contingentement qualitatif strict à partir du 23 avril 2026
2. [Latest News]
3. Use of macrolides, lincosamides and streptogramins (MLS) in animals in the European Union - Scientific guideline - 2026-04-24
4. Thédéen: Vulnerabilities and resilience in a new world order
5. Press release - Rule of law in the EU: press conference on Tuesday 28 April at 15.30 CEST
6. Minutes - Executive steering group on shortages and safety of medicinal products (MSSG) - 23 March 2026 - 2026-04-24
7. EPA Seeks Public Input for Proposed Plan to Address Groundwater Contamination at Baird & McGuire Superfund Site
8. United States Files Complaint Against DC Water in Response to Potomac Interceptor Collapse
9. 20/04/2026 - Agenda of CHMP meeting 20-23 April 2026
10. 更好发挥节能降碳对推进碳达峰碳中和支撑作用——解读《关于更高水平更高质量做好节能降碳工作的意见》